DEN · Denbury Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $1.71B | $1.26B | - | $1.27B | $1.47B | $1.13B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $82.18M | $79.26M | - | $83.03M | $71.50M | $101.81M |
| Total Operating Expenses | $1.16B | $1.20B | - | $953.57M | $1.06B | $1.08B |
| D&A | $151.43M | $150.64M | - | $233.82M | $216.45M | $207.71M |
| Operating Income | $555.00M | $56.77M | - | $321.31M | $409.93M | $46.50M |
| Interest Expense | $4.03M | $4.15M | - | $81.63M | $69.69M | $99.26M |
| Income Tax | $74.84M | $767.0K | - | $104.35M | $87.23M | ($116.65M) |
| Net Income | $480.16M | $56.00M | - | $216.96M | $322.70M | $163.15M |
| EPS - Basic | $9.34 | $1.10 | - | $0.47 | $0.75 | $0.42 |
| EPS - Diluted | $8.83 | $1.04 | - | $0.45 | $0.71 | $0.41 |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $521.0K | $45.59M | $518.0K | $516.0K | $38.56M | $58.0K |
| Accounts Receivable | $10.83M | $36.22M | $19.68M | $18.32M | $26.97M | $45.19M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $58.91M | $25.70M | $18.63M | - | - | - |
| Current Assets | $206.23M | $175.41M | $126.85M | $180.61M | $296.29M | $202.25M |
| Total Assets | $2.33B | $1.90B | $1.63B | $4.69B | $4.72B | $4.47B |
| Current Liabilities | $346.86M | $313.30M | $285.06M | $364.24M | $364.79M | $458.06M |
| Long-term Debt | - | $35.00M | $138.01M | $2.28B | $2.53B | $2.78B |
| Total Liabilities | - | $342.69M | - | - | - | - |
| Stockholders' Equity | $1.53B | $1.14B | $1.05B | $1.41B | $1.14B | $648.16M |
| Retained Earnings | $485.50M | $5.34M | ($50.66M) | ($1.32B) | ($1.53B) | ($1.86B) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $520.75M | $317.16M | - | $529.68M | $529.68M | $267.14M |
| Investing Cash Flow | ($427.93M) | ($202.93M) | - | ($269.69M) | ($333.28M) | ($357.30M) |
| Financing Cash Flow | ($95.28M) | ($106.13M) | - | $88.61M | ($157.45M) | $88.61M |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 32.4% | 4.5% | - | 25.2% | 27.8% | 4.1% |
| EBITDA margin | 41.2% | 16.5% | - | 43.5% | 42.5% | 22.5% |
| Net margin | 28.0% | 4.5% | - | 17.0% | 21.9% | 14.4% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 4.8% | 6.3% | - | 6.5% | 4.9% | 9.0% |
| Effective tax rate | 13.5% | 1.4% | - | 32.5% | 21.3% | -250.9% |
| Return on assets | 20.6% | 2.9% | - | 4.6% | 6.8% | 3.6% |
| Return on equity | 31.3% | 4.9% | - | 15.4% | 28.3% | 25.2% |
| Return on invested capital | - | 4.8% | - | 5.9% | 8.8% | 1.4% |
| Liquidity | ||||||
| Current ratio | 0.59 | 0.56 | 0.44 | 0.50 | 0.81 | 0.44 |
| Quick ratio | 0.59 | 0.56 | 0.44 | 0.50 | 0.81 | 0.44 |
| Cash ratio | 0.00 | 0.15 | 0.00 | 0.00 | 0.11 | 0.00 |
| Leverage | ||||||
| Debt / Equity | - | 0.03 | 0.13 | 1.62 | 2.22 | 4.28 |
| Debt / Assets | - | 0.02 | 0.08 | 0.49 | 0.54 | 0.62 |
| Debt / EBITDA | - | 0.17 | - | 4.11 | 4.04 | 10.92 |
| Interest coverage | 137.9x | 13.7x | - | 3.9x | 5.9x | 0.5x |
| Equity multiplier | 1.52 | 1.68 | 1.55 | 3.32 | 4.14 | 6.90 |
| Liabilities / Assets | - | 0.18 | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.74 | 0.66 | - | 0.27 | 0.31 | 0.25 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 2d | 11d | - | 5d | 7d | 15d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 36.3% | - | - | -13.5% | 30.4% | 15.8% |
| Revenue CAGR (3y) | 10.4% | -5.1% | - | 9.3% | 5.4% | -22.8% |
| Revenue CAGR (5y) | 8.7% | 5.2% | - | -12.3% | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 877.7% | - | - | -21.6% | 781.6% | - |
| Net income growth (YoY) | 757.4% | - | - | -32.8% | 97.8% | - |
| EPS growth (YoY) | 749.0% | - | - | -36.6% | 73.2% | - |
| EPS CAGR (3y) | 169.7% | 13.6% | - | - | - | -39.0% |
| EPS CAGR (5y) | 84.8% | - | - | -24.3% | -8.5% | -21.2% |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 35.0% | 7.8% | -25.4% | 23.7% | 76.2% | 38.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2022-12-31.
Product / service
$3.28B totalOil And Gas$1.58B · 48.1%
Oil Reserves$1.56B · 47.5%
Oil Marketing$65.09M · 2.0%
Carbon Dioxide$60.57M · 1.8%
Natural Gas Reserves$19.57M · 0.6%
Stability scores
Piotroski F-score
FY 2022 · 9-point quality
7/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Crude Petroleum & Natural Gas
Comparing DENBURY INC against the 5 most active filers in the same SIC group.